Different effects of dexamethasone and the nitric oxide synthase inhibitor L-NAME on caerulein-induced rat acute pancreatitis, depending on the severity

Inflammopharmacology

Volumn 13, Issue 1-3, 2005, Pages 291-301

  Sugiyama, Yusuke ^a   Kato, Shinichi ^b   Abe, Mitsumasa ^a   Mitsufuji, Shoji ^a   Takeuchi, Koji ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Caerulein induced acute pancreatitis; Dexamethasone; N G nitro L arginine methyl ester (L NAME); Nitric oxide

Indexed keywords

AMYLASE; CERULETIDE; DEXAMETHASONE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ADMINISTRATION, ORAL; AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAERULEIN; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INJECTIONS, SUBCUTANEOUS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGAN SIZE; PANCREAS; PANCREATITIS; PEROXIDASE; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX;

EID: 27744496585     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856005774423728     Document Type: Article

References (33)

1. Abe, M., Kato, S., Okayama, M., et al. (2004). Prophylactic effect of restraint stress on caerulein-induced pancreatitis in rats: role of endogeneous glucocorticoids, Dig. Dis. Sci. 49, 521-528.
2. Abe, R., Shimosegawa, T., Kimura, K., et al. (1995). The role of endogenous glucocorticoids in rat experimental models of acute pancreatitis, Gastroenterology 109, 933-943.
3. Ader, R. and Friedman, S. B. (1968). Plasma corticosterone response to environmental stimulation: effect of duration of stimulation and the 24-hour adrenocortical rhythm, Neuroendocrinology 3, 378-386.
4. Anderson, M. C., Booher, D. L. and Lim, R. B. (1964). Treatment of acute pancreatitis with adrenocorticosteroids, Surgery 55, 551-558.
5. Bencosme, S. A. and Lazarus, S. S. (1956). The pancreas of cortisone-treated rabbits: a pathogenic study, Arch. Pathol. 62, 285-295.
6. Beutler, B., Krochin, N., Milsark, I. W., et al. (1986). Control of cachccin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance, Science 232, 977-980.
7. Bradley, P. P., Priebat, D. A., Christensen, R. D., et al. (1982). Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker, J. Invest. Dermatol. 78, 206-209.
8. Carone, F. A. and Liebow, A. A. (1957). Acute pancreatic lesions in patients treated with ACTH and adrenal corticoids, N. Engl. J. Med. 257, 690.
9. Cunha, F. Q. and Ferreira, S. H. (1986). The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids, Eur. J. Pharmacol. 23, 65-76.
10. Dabrowski, A. and Gabryelewicz, A. (1994). Nitric oxide contributes to multiorgan oxidative stress in acute experimental pancreatitis, Scand. J. Gastrowenterol. 29, 943-948.
11. De Dios, I., San Roman, J. I., Manso, M., et al. (1990). Glucocorticoid effects on exocrine pancreatic secretion in caerulein-induced acute pancreatitis in the rat, Arch. Int. Physiol. Biochem. 98, 361-370.
12. De Palma, G. and Catanzano, C. (1999). Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study, Am. J. Gastroenterol. 94, 982-985.
13. Di Rosa, M., Radomski, M., Carnuccio, R., et al. (1990). Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages, Biochem. Biophys. Res. Commun. 172, 1246-1252.
14. Dunn, J., Scheving, L. and Millet, P. (1972). Circadian variation in stress-evoked increases in plasma corticosterone, Am. J. Physiol. 223, 402-406.
15. Liu, X., Nakano, I., Yamaguchi H., et al. (1995). Protective effect of nitric oxide on development of acute pancreatitisin rats, Dig. Dis. Sci. 40, 2162-2169.
16. Lomis, T. J., Siffring, C. W., Chalasani, S., et al. (1995). Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis, Am. Surg. 61, 7-10.
17. Molero, X., Guarner, F., Salas, A., et al. (1995). Nitric oxide modulates pancreatic basal secretion and response to caerulein in the rat: effects in acute pancreatitis, Gastroenterology 108, 1855-1862.
18. Moncada, S. and Higgs, A. (1993). The L-arginine-nitric oxide pathway, N. Engl. J. Med. 329, 2002-2012.
19. Moncada, S., Palmer, R. M. J. and Higgs, A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43, 109-142.
20. Munk, A., Guyre, P. M. and Holbrook, N. J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions, Endocr. Rev. 5, 23-44.
21. Nakashima, Y. and Howard, J. M. (1977). Drug-induced acute pancreatitis, Surg. Gynecol. Obstet. 145, 105-109.
22. Nelp, W. B., Banwell, J. G. and Hendrix, T. R. (1961). Pancreatic function and the viscosity of pancreatic juice before and during cortisone administration, Bull. Johns Hopkins Hosp. 109, 292.
23. Ogawa, K., Matsui, H. and Usui, T. (1992). Differential assay of human pancreatic and salivary alpha-amylases with p-nitrophenyl 65-o-beta-D- galacopyraosyl-alpha-maltopentaoside as the subtrate, Biosci. Biotech. Biochem. 56, 1933-1936.
24. Oppenheimer, E. H. and Boitnott, J. K. (1960). Pancreatitis in children following adrenal corticosteroid therapy, Bull. Johns Hopkins Hosp. 107, 297.
25. Patel, A. G., Toyama, M. T., Nguyen, T. N., et al. (1995). Role of nitric oxide in the relationship of pancreatic blood flow and exocrine secretion in cats, Gastroenterology 108, 1215-1220.
26. Peters-Golden, M., Bathon, J., Flores, R., et al. (1984). Glucocorticoid inhibition of zymosan-induced arachidonic acid released by rat alveolar macrophages, Am. Rev. Respir. Dis. 130, 803-809.
27. Stewart, W. C., Elliot, D. W. and Zollinger, R. M. (1958). Cortisone in the treatment of experimental acute pancreatitis, Surg. Forum. 9, 537-541.
28. Stumpf, H. H., Wilens, S. L. and Somaza, C. (1956). Pancreatic lesions and peripancreatic fat necrosis in cortisone-treated rabbits, Lab. Invest. 5, 224-235.
29. Usui, T., Ogawa, K., Nagai, H., et al. (1992). Enzymic synthesis of p-nitrophenyl 65-o-beta-D-galacopyraosyl-alpha-maltopentaoside as the substrate for human alpha-amylases, Anal. Biochem. 202, 61-67.
30. Weidenbach, H., Lerch, M. M., Gress, T. M., et al. (1995). Vasoactive mediators and the progression from oedematous to necrotizing experimental acute pancreatitis, Gut 37, 23-30.
31. Weiner, G. R. W., Geenen, J. E., Hogan, W. J., et al. (1995). Use of corticosteroids in the prevention of post-ERCP pancreatitis, Gastrointest. Endosc. 42, 579-583.
32. Werner, J., Rivera, J., Fernandez-del Castillo, C., et al. (1997). Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis, Surgery 121, 23-30.
33. Zion, M. M., Goldberg, B. and Suzman, M. M. (1995). Corticotrophin and cortisone in the treatment of sclerodema, Q. J. Med. 24, 215.